1. Home
  2. DNUT vs CSTL Comparison

DNUT vs CSTL Comparison

Compare DNUT & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$4.28

Market Cap

781.1M

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$39.40

Market Cap

661.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNUT
CSTL
Founded
1937
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
781.1M
661.7M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
DNUT
CSTL
Price
$4.28
$39.40
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$6.22
$42.83
AVG Volume (30 Days)
2.7M
364.8K
Earning Date
11-06-2025
11-03-2025
Dividend Yield
1.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,534,272,000.00
$343,530,000.00
Revenue This Year
N/A
$1.69
Revenue Next Year
$0.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
10.15
52 Week Low
$2.50
$14.59
52 Week High
$10.06
$42.18

Technical Indicators

Market Signals
Indicator
DNUT
CSTL
Relative Strength Index (RSI) 51.23 61.26
Support Level $4.16 $37.76
Resistance Level $4.72 $42.18
Average True Range (ATR) 0.19 1.22
MACD -0.04 -0.29
Stochastic Oscillator 21.19 52.48

Price Performance

Historical Comparison
DNUT
CSTL

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: